(Q49697799)

English

The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols

scientific article published on 7 January 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols (English)

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

0 references

0 references

1 reference

based on heuristic

inferred from title

Ellis J Neufeld

6

object named as

Ellis J Neufeld

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

3

object named as

Donna Neuberg

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

author name string

Rachael F Grace

1

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

Suzanne E Dahlberg

2

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

Stephen E Sallan

4

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

Jean M Connors

5

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

Daniel J Deangelo

7

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

Lewis B Silverman

8

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

language of work or name

0 references

publication date

7 January 2011

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

British Journal of Haematology

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

152

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

4

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

452-459

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Thrombosis and acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Increased risk of venous thromboembolism in patients with acute leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

22 May 2018

Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Effects of Erwinia-asparaginase on the coagulation system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

14 August 2018

Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL stu

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5763913

2 November 2018

Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08524.X

21 January 2018

Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developmental haemostasis. Impact for clinical haemostasis laboratories

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in coagulation and fibrinolysis in childhood ALL: a two-step dose reduction of one E. coli asparaginase preparation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21210774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2141.2010.08524.X

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 February 2018

http://europepmc.org/abstract/PMC/5763913

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49697799&oldid=2227604640"